Less Ads, More Data, More Tools Register for FREE

Pin to quick picksXeros Tech Regulatory News (XSG)

Share Price Information for Xeros Tech (XSG)

Share Price is delayed by 15 minutes
Get Live Data
1.425    0.00 (0.00%)
Bid:
1.35
Ask:
1.50
Spread: 0.15 (11.111%)
Market Cap: £12.28m
XSG Live PriceLast checked at - London Stock Exchange

Intraday Xeros Tech Share Chart

PrimaryBid.com Offer

24 Apr 2020 11:00

RNS Number : 8052K
Xeros Technology Group plc
24 April 2020
 

THIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION FOR THE PURPOSES OF ARTICLE 7 OF THE MARKET ABUSE REGULATION (EU) 596/2014.

THIS ANNOUNCEMENT IS FOR INFORMATIONAL PURPOSES ONLY, AND DOES NOT CONSTITUTE OR FORM PART OF ANY OFFER OR INVITATION TO SELL OR ISSUE, OR ANY SOLICITATION OF AN OFFER TO PURCHASE OR SUBSCRIBE FOR, ANY SECURITIES OF XEROS TECHNOLOGY GROUP PLC.

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN OR INTO, OR TO ANY PERSON LOCATED OR RESIDENT IN, ANY JURISDICTION WHERE IT IS UNLAWFUL TO RELEASE, PUBLISH OR DISTRIBUTE THIS ANNOUNCEMENT.

THIS ANNOUNCEMENT AMOUNTS TO A FINANCIAL PROMOTION FOR THE PURPOSES OF SECTION 21 OF THE FINANCIAL SERVICES AND MARKETS ACT 2000 ("FSMA") AND HAS BEEN APPROVED BY PRIMARYBID LIMITED WHICH IS AUTHORISED AND REGULATED BY THE FINANCIAL CONDUCT AUTHORITY (FRN 779021)

 

 

 

 

Xeros Technology Group plc 

("Xeros" or the "Company")

PrimaryBid.com Offer

 

Xeros Technology Group plc (AIM: XSG), the developer and provider of water saving and filtration technologies with multiple commercial and domestic applications, is pleased to announce that following the completion of a placing of 1,140,000,000 new Ordinary Shares at 0.5 pence per share as announced at 11.00am on 24 April 2020 (the "Placing"), there is an opportunity for retail investors to participate in this fundraising through a further dedicated issue of up to 60,000,000 new Ordinary Shares at a fixed issue price of 0.5 pence per new Ordinary Share (the "Issue Price") via PrimaryBid being a discount of 33.42 per cent to the closing mid-price on 23 April 2020 (the "PrimaryBid Offer").

The PrimaryBid Offer and the Placing are conditional, inter alia, on the passing of the resolutions at the general meeting and also on the new Ordinary Shares to be issued pursuant to the PrimaryBid Offer and the Placing being admitted to trading on AIM ("Admission"). Admission is expected to be take place at 8.00 a.m. on 14 May 2020. The PrimaryBid Offer will not be completed without the Placing also being completed.

The Company will use the funds raised for the Company's current portfolio of contracts and development agreements with EBITDA cash break-even expected Q2 2022.

PrimaryBid Offer

The Company values its retail investor base and is therefore pleased to provide private and other investors the opportunity to participate in the PrimaryBid Offer by applying exclusively through the www.PrimaryBid.com platform and the PrimaryBid mobile app available on the Apple App Store and Google Play. PrimaryBid does not charge investors any commission for this service.

The PrimaryBid Offer, via the PrimaryBid.com platform, will be open to individual and institutional investors from 11.01a.m. on 24 April 2020 to 3.30 p.m. on 24 April 2020. The PrimaryBid Offer may close early if it is oversubscribed.

Subscriptions under the PrimaryBid Offer will be considered by the Company on a "first come, first served" basis, subject to conditions (which are available to view on PrimaryBid.com).

No commission is charged to investors on applications to participate in the PrimaryBid Offer made through PrimaryBid. It is vital to note that once an application for new Ordinary Shares has been made and accepted via PrimaryBid, an application cannot be withdrawn.

For further information on PrimaryBid.com or the procedure for applications under the PrimaryBid Offer, visit www.PrimaryBid.com or call PrimaryBid.com on +44 20 3026 4750. 

The new Ordinary Shares will be issued free of all liens, charges and encumbrances and will, when issued and fully paid, rank pari passu in all respects with the Company's existing ordinary shares.

Xeros Technology Group plc

Mark Nichols, CEO

Paul Denney, CFO

www.xerostech.com 

0114 321 6328

PrimaryBid Limited

Kieran D'Silva / James Deal

 

+44 (0) 20 3026 4750

finnCap

Julian Blunt, Teddy Whiley (Corporate Finance)

Andrew Burdis, Sunila de Silva (ECM)

www.finncap.com

+44 (0) 20 7220 0500

 

 

Details of the PrimaryBid Offer

The Company highly values its retail investor base which has supported the Company alongside institutional investors over several years. Given the longstanding support of retail shareholders, the Company believes that it is appropriate to provide retail and other interested investors the opportunity to participate in the PrimaryBid Offer. The Company is therefore making the PrimaryBid Offer available exclusively through PrimaryBid.com.

The PrimaryBid Offer is offered under the exemptions against the need for a prospectus allowed under the Prospectus Rules. As such, there is no need for publication of a prospectus pursuant to the Prospectus Rules, or for approval of the same by the Financial Conduct Authority in its capacity as the UK Listing Authority. The PrimaryBid Offer is not being made into any Restricted Jurisdiction or any other jurisdiction where it would be unlawful to do so.

The PrimaryBid Offer is open to existing shareholders and other individual investors subscribing via PrimaryBid.com. There is a minimum subscription of £100 per investor under the terms of the PrimaryBid Offer and the allocation will be filled on a "first come first served" basis.

The Company in consultation with PrimaryBid reserves the right to scale back any order at its discretion.

For further details please refer to www.PrimaryBid.com. The terms and conditions on which the PrimaryBid Offer is made, including the procedure for application and payment for New Ordinary Shares, is available to all persons who register with PrimaryBid.com.

It should be noted that a subscription for new Ordinary Shares and investment in the Company carries a number of risks. Investors should make their own investigations into the merits of an investment in the Company. Nothing in this announcement amounts to a recommendation to invest in the Company or amounts to investment, taxation or legal advice. Investors should take independent advice from a person experienced in advising on investment in securities such as the new Ordinary Shares if they are in any doubt. 

 

END

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
IOEPPUQCCUPUUBC
Date   Source Headline
3rd Aug 20209:30 amRNSApplication for Block Listing
22nd Jul 20209:15 amRNSBlock Listing Six Monthly Return
16th Jul 20204:21 pmRNSHolding(s) in Company
16th Jul 20207:00 amRNSXFiltra rated best laundry microparticle filter
14th Jul 20204:41 pmRNSSecond Price Monitoring Extn
14th Jul 20204:36 pmRNSPrice Monitoring Extension
11th Jun 202010:00 amRNSResult of AGM
3rd Jun 20202:45 pmRNSHolding(s) in Company
1st Jun 202012:30 pmRNSHolding(s) in Company
1st Jun 20207:00 amRNSCompletion of Sale of Marken Business
27th May 20207:00 amRNSXeros technology cleaning French key worker PPE
26th May 20204:00 pmRNSHolding(s) in Company
20th May 20204:15 pmRNSHolding(s) in Company
19th May 20204:45 pmRNSPublication of Annual Report & Notice of AGM
15th May 20203:15 pmRNSHolding(s) in Company
14th May 20205:45 pmRNSHolding(s) in Company
14th May 20208:01 amRNSDirector/PDMR Shareholding, Issue of Options & TVR
13th May 202011:00 amRNSResult of General Meeting
12th May 20204:40 pmRNSSecond Price Monitoring Extn
12th May 20204:35 pmRNSPrice Monitoring Extension
24th Apr 20203:30 pmRNSResult of Fundraising
24th Apr 202011:00 amRNSPrimaryBid.com Offer
24th Apr 202011:00 amRNSProposed Placing, PrimaryBid Offer & Notice of GM
24th Apr 202011:00 amRNSUnaudited Preliminary Results
14th Apr 20204:40 pmRNSSecond Price Monitoring Extn
14th Apr 20204:36 pmRNSPrice Monitoring Extension
26th Mar 20207:00 amRNSFormer C&A Innovation Head Advises Xeros
19th Mar 20207:00 amRNSLicensing Agreement With Leading Asian OEM
17th Mar 20207:00 amRNSDevelopment Agreement for Microplastic Filtration
16th Mar 20204:42 pmRNSSecond Price Monitoring Extn
16th Mar 20204:37 pmRNSPrice Monitoring Extension
16th Mar 202012:08 pmRNSSecond Price Monitoring Extn
16th Mar 202012:02 pmRNSPrice Monitoring Extension
12th Mar 202012:07 pmRNSSecond Price Monitoring Extn
12th Mar 202012:02 pmRNSPrice Monitoring Extension
3rd Mar 20207:00 amRNSSale of Marken Business
21st Jan 20202:02 pmRNSBlock Listing Six Monthly Return
16th Jan 202012:07 pmRNSSecond Price Monitoring Extn
16th Jan 202012:02 pmRNSPrice Monitoring Extension
13th Jan 202012:00 pmRNSDirectorate Change
2nd Dec 20194:40 pmRNSSecond Price Monitoring Extn
2nd Dec 20194:35 pmRNSPrice Monitoring Extension
26th Nov 201911:24 amRNSHolding(s) in Company
22nd Nov 20195:51 pmRNSHolding(s) in Company
22nd Nov 20192:52 pmRNSHolding(s) in Company
22nd Nov 201912:12 pmRNSHolding(s) in Company
22nd Nov 20199:34 amRNSHolding(s) in Company
21st Nov 20192:00 pmRNSHolding(s) in Company
20th Nov 20194:45 pmRNSHolding(s) in Company
20th Nov 201910:00 amRNSDirector/PDMR Shareholding & Total Voting Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.